Holdings
Putnam Global Health Care Fund
As of May 31, 2026, Putnam Global Health Care Fund reported 38 positions worth US$1.44B. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 174K | US$193M | +2,880 | May 31, 2026 |
| Johnson & Johnson | 550K | US$124M | −19,800 | May 31, 2026 |
| Unitedhealth Group Incorporated | 267K | US$102M | no change | May 31, 2026 |
| Abbvie Inc. | 407K | US$88.6M | no change | May 31, 2026 |
| Novartis Ag | 500K | US$75.2M | −23,097 | May 31, 2026 |
| Merck & Company, Inc. | 602K | US$71.5M | −82,700 | May 31, 2026 |
| Astrazeneca Plc | 369K | US$68.4M | −12,601 | May 31, 2026 |
| Thermo Fisher Scientific Inc | 134K | US$65.9M | +20,960 | May 31, 2026 |
| Intuitive Surgical, Inc. | 139K | US$59.2M | +16,320 | May 31, 2026 |
| Sanofi Sa | 540K | US$47.4M | +160K | May 31, 2026 |